PRA Health Sciences Inc (PRAH) stock has risen 92.83% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives PRAH stock a score of 67 out of a possible 100.
That rank is influenced by a long-term technical score of 98. PRAH's rank also includes a short-term technical score of 93. The fundamental score for PRAH is 9. In addition to the average rating from Wall Street analysts, PRAH stock has a mean target price of 142.833. This means analysts expect the stock to lose 11.82% over the next 12 months.
What's Happening with PRAH Stock Today
PRA Health Sciences Inc (PRAH) stock has risen 3.89% while the S&P 500 has risen 1.07% as of 12:55 PM on Thursday, Apr 15. PRAH has risen $6.07 from the previous closing price of $155.91 on volume of 958,916 shares. Over the past year the S&P 500 is up 49.78% while PRAH has risen 92.83%. PRAH earned $3.04 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 53.23.
Click Here to get the full Stock Score Report on PRA Health Sciences Inc (PRAH) Stock.